| Patent Number |
Title Of Patent |
Date Issued |
| RE31965 |
Compliantly mountable turbine cartridge assembly for gas-driven dental handpiece |
August 6, 1985 |
| A single-unit turbine cartridge assembly for a gas-driven dental handpiece includes a pair of bearing assemblies mounted on a turbine rotor shaft and a ring of resilient material around each bearing assembly. The resilient ring provides radial support for the turbine cartridge assembly w |
| RE31406 |
Oxygen permeable contact lens composition, methods and article of manufacture |
October 4, 1983 |
| Contact lenses are fabricated from a copolymer of a polysiloxanylalkyl acrylic ester and an alkyl acrylic ester. The copolymer has increased oxygen permeability. |
| RE28819 |
Dialkylated glycol compositions and medicament preparations containing same |
May 18, 1976 |
| A pharmaceutical preparation having a minor amount of a medicament, a major amount of a dialkylated mono- or poly-alkylene glycol vehicle therefor, and a minor amount of one or more antioxidants for the dialkylated glycol vehicle. |
| D294807 |
Cassette for chromatograph |
March 22, 1988 |
|
| D291185 |
Chromatography cassette |
August 4, 1987 |
|
| D286481 |
Cabinet door or similar article |
November 4, 1986 |
|
| D286177 |
Cabinet door |
October 14, 1986 |
|
| D285395 |
Drawer front or similar article |
September 2, 1986 |
|
| D282992 |
Combined cup and towel dispenser |
March 18, 1986 |
|
| D282683 |
Operatory module system for a health treatment facility |
February 18, 1986 |
|
| D282682 |
Operatory module for a health treatment facility |
February 18, 1986 |
|
| D282681 |
Operatory module for a health treatment facility |
February 18, 1986 |
|
| D282575 |
Operatory module for a health treatment facility |
February 11, 1986 |
|
| D282574 |
Operatory module for a health treatment facility |
February 11, 1986 |
|
| D282573 |
Operatory module for a health treatment facility |
February 11, 1986 |
|
| D282572 |
Operatory module for a health treatment facility |
February 11, 1986 |
|
| D282571 |
Operatory module for a health treatment facility |
February 11, 1986 |
|
| D281656 |
Seating unit for a patient's chair |
December 10, 1985 |
|
| D280517 |
Transparency viewer |
September 10, 1985 |
|
| D268149 |
Dental chair |
March 8, 1983 |
|
| D266109 |
Dental scaler |
September 7, 1982 |
|
| D261301 |
Dental handpiece |
October 13, 1981 |
|
| D261032 |
Dental handpiece |
September 29, 1981 |
|
| D260703 |
Dental chair |
September 15, 1981 |
|
| D259362 |
Dental bur wrench tool |
May 26, 1981 |
|
| D248101 |
Electronic control and display console |
June 6, 1978 |
|
| D246111 |
Axial tomographic scanner housing |
October 18, 1977 |
|
| 7186841 |
Antiinflammation agents |
March 6, 2007 |
| Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic and cell proliferative conditions or diseases are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of protei |
| 7141365 |
Methods for diagnosing a mucin production associated disease condition |
November 28, 2006 |
| Methods and compositions for modulating mucin secretion by respiratory system cells are provided. In the subject methods, an effective amount of an hCLCA2 (or homolog thereof) modulatory agent is contacted with the cell to modulate mucin secretion, e.g., decrease or increase mucin se |
| 7122325 |
Method of modulating tetrotodoxin-resistant sodium channel |
October 17, 2006 |
| The present invention relates to a voltage-gated sodium channel present in peripheral nerve tissue that is tetrodotoxin-resistant. One aspect of the present invention is purified and isolated DNA encoding this sodium channel. Another aspect of the present invention is the recombinant |
| 7094778 |
Heterocyclylalkylamines as muscarinic receptor antagonists |
August 22, 2006 |
| This invention relates to compounds which are generally muscarinic M2/M3 receptor antagonists and which are represented by Formula I: ##STR00001## wherein X, Y, and Z are O, S or NR.sup.5, and the other substituents are as defined in the specification; and prodrugs, individual isomers, |
| 7094591 |
Human aggrecanase and nucleic acid compositions encoding the same |
August 22, 2006 |
| Human aggrecanase and polypeptides related thereto, as well as nucleic acid compositions encoding the same, are provided. The subject polypeptides and nucleic acid compositions find use in a variety of applications, including research, diagnostic, and therapeutic agent screening appl |
| 7074763 |
Stable formulations of nerve growth factor |
July 11, 2006 |
| Aqueous formulations of nerve growth factor suitable for lyophilization and subsequent reconstitution in which nerve growth factor is admixed with sugars and buffer are provided. |
| 7071177 |
P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
July 4, 2006 |
| This invention relates to anti-inflammatory and analgesic compounds, especially to certain p-(sulfonyl)phenyl amino derivatives, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds. |
| 7070971 |
Glycosyl sulfotransferases GST-4.alpha., GST-4.beta., and GST-6 |
July 4, 2006 |
| Novel glycosylsulfotransferases (GST-4.alpha., GST-4.beta., and GST-6) and polypeptides related thereto, as well as nucleic acid compositions encoding the same, are provided. The subject polypeptides and nucleic acid compositions find use in a variety of applications, including vario |
| 7056903 |
Carboxylic acid derivatives as IP antagonists |
June 6, 2006 |
| This invention relates to compounds which are generally IP receptor antagonists and which are represented by Formula I: ##STR00001## wherein: R.sup.1, R.sup.2, and R.sup.3 are each independently in each occurrence aryl or heteroaryl; R.sup.4 is --COOH or tetrazolyl; A, B, m, n, and |
| 7053103 |
Ring fused pyrazole derivatives as CRF antagonists |
May 30, 2006 |
| This invention relates to compounds which are generally CRF-1 receptor antagonists and which are represented by Formula I or Formula II: ##STR00001## wherein Ar is optionally substituted aryl or heteroaryl, R.sup.1 R.sup.4 are as defined in the specification; or individual isomers, |
| 7049325 |
Quinoline derivatives as anti-inflammatory agents |
May 23, 2006 |
| This invention relates to compounds, which are generally anti-inflammatory and analgesic compounds, and which are represented by Formula I: ##STR00001## wherein A is a CH.sub.2, CH(OH), C(O), C.dbd.NOR.sup.4, NR.sup.5, O, S, S(O), or S(O).sub.2, and the other substituents are as def |
| 7049317 |
CCR-3 receptor antagonists |
May 23, 2006 |
| The invention provides compounds of Formula (I): ##STR00001## wherein R.sub.1 R.sub.4 have any of the values defined in the specification that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use, and methods and intermediates useful for |
| 7019007 |
CCR-3 receptor antagonists (I) |
March 28, 2006 |
| The invention provides compounds of Formula (I): ##STR00001## wherein: R.sup.1 R.sup.4, A, D, and L have any of the values defined in the specification that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use, and methods and intermedi |
| 6984637 |
Cyclic amine derivatives-CCR-3 receptor antagonists |
January 10, 2006 |
| This invention relates to certain cyclic amine derivatives of Formula (I) ##STR00001## that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds. |
| 6979693 |
Pyrazole derivatives-p38 MAP kinase inhibitors |
December 27, 2005 |
| The present invention relates to certain pyrazole derivatives of Formula (I): ##STR1##that are p-38 MAP kinase inhibitors, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds. |
| 6967093 |
Glycosyl sulfotransferase-3 |
November 22, 2005 |
| A novel human glycosylsulfotransferase expressed in high endothelial cells (GST-3) and polypeptides related thereto, as well as nucleic acid compositions encoding the same, are provided. The subject polypeptides and nucleic acid compositions find use in a variety of applications, includi |
| 6951918 |
Peptidic procollagen C-proteinase inhibitors |
October 4, 2005 |
| This invention relates to compounds of Formula (I) ##STR1##wherein R.sup.1 -R.sup.7, A, Z and n are as described in the Summary of the Invention that are inhibitors of procollagen C-proteinase, pharmaceutical compositions containing them, methods for their use and methods for their p |
| 6933142 |
HEC-G1CNAC6ST |
August 23, 2005 |
| Mammalian glycosylsulfotransferases expressed in high endothelial cells (HEC-GLCNAC6ST) and polypeptides related thereto, as well as nucleic acid compositions encoding the same, are provided. The subject polypeptides and nucleic acid compositions find use in a variety of applications, in |
| 6903086 |
Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP anta |
June 7, 2005 |
| This invention relates to compounds which are generally IP receptor antagonists and which are represented by Formula I: ##STR1##wherein G.sup.1 is selected from the group consisting of a, b.sup.1 and b.sup.2, ##STR2##and A and G.sup.2 are as defined in the specification; or pharmaceu |
| 6900336 |
8-aza-11-deoxy prostaglandin analogues |
May 31, 2005 |
| This invention relates to compounds which are generally EP.sub.4 receptor agonists and which are represented by Formula I: ##STR1##wherein A is a --CH.sub.2 --CH.sub.2 --, or --CH.dbd.CH--; B is absent, an aryl, or heteroaryl group; R.sup.1 is alkyl, alkenyl, alkynyl, cycloalkylalkyl |
| 6900220 |
Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists |
May 31, 2005 |
| This invention relates to compounds which are generally alpha-1A/B adrenoceptor antagonists and which are represented by Formula I: ##STR1##wherein Z is --C(O)-- or --S(O).sub.2 --, X is carbon or nitrogen, Y is carbon, and X--Y considered together are two adjoining atoms of the ring |
| 6893842 |
T-type calcium channel variants; compositions thereof; and uses |
May 17, 2005 |
| The invention provides TCCV-1 or TCCV-2 from human, reagents related thereto including polynucleotides encoding TCCV-1 or TCCV-2, purified polypeptides, and specific antibodies. Methods of making and using these reagents, in particular, methods for screening compounds which modulate |
| 6872744 |
Indole derivatives as anti-inflammatory agents |
March 29, 2005 |
| This invention relates to compounds, which are generally anti-inflammatory and analgesic compounds, and which are represented by Formula I: ##STR1##wherein A is a --CH.sub.2 --, --O--, --S--, or --S(O)--; and the other substituents are as defined in the specification; or individual isome |
